Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cardiac Science closes Artema purchase:

This article was originally published in Clinica

Executive Summary

Almost 95% of the shareholders of Swedish patent monitor and defibrillator manufacturer Artema Medical had accepted the takeover offer from Cardiac Science by the final application date of November 23. The Irvine, California company was planning to complete the share exchange on November 30, and said its consideration would amount to around four million shares. The company also planned to compulsorily purchase to the outstanding shares and seek a delisting of the Stockholm company's shares. Artema will bring an expanded in-hospital defibrillator line, enhanced distribution in Europe, the Middle East and Asia, and an installed base of some 6,000 patient monitors. CLINICA -World Medical Device & Diagnostic News FILED 27 November 2001 COPYRIGHT 2001 PJB Publications Ltd





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts